Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases.
| Last: | $0.3113 |
|---|---|
| Change Percent: | -76.68% |
| Open: | $0.55 |
| Close: | $0.3113 |
| High: | $0.555 |
| Low: | $0.27 |
| Volume: | 12,453,600 |
| Last Trade Date Time: | 07/16/2025 03:40:41 pm |
| Market Cap: | $1,619,184 |
|---|---|
| Float: | 8,014,962 |
| Insiders Ownership: | 7.09% |
| Institutions: | 7 |
| Short Percent: | 517010% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.zyversa.com |
| Country: | US |
| City: | Weston |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about ZyVersa Therapeutics Inc. (NASDAQ: ZVSA).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
